The effect of prolonged spaceflight on cerebrospinal fluid and perivascular spaces of astronauts and cosmonauts.
brain
microgravity
perivascular space
spaceflight
spaceflight-associated neuroocular syndrome
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
26 04 2022
26 04 2022
Historique:
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
15
4
2022
Statut:
ppublish
Résumé
Long-duration spaceflight induces changes to the brain and cerebrospinal fluid compartments and visual acuity problems known as spaceflight-associated neuro-ocular syndrome (SANS). The clinical relevance of these changes and whether they equally affect crews of different space agencies remain unknown. We used MRI to analyze the alterations occurring in the perivascular spaces (PVS) in NASA and European Space Agency astronauts and Roscosmos cosmonauts after a 6-mo spaceflight on the International Space Station (ISS). We found increased volume of basal ganglia PVS and white matter PVS (WM-PVS) after spaceflight, which was more prominent in the NASA crew than the Roscosmos crew. Moreover, both crews demonstrated a similar degree of lateral ventricle enlargement and decreased subarachnoid space at the vertex, which was correlated with WM-PVS enlargement. As all crews experienced the same environment aboard the ISS, the differences in WM-PVS enlargement may have been due to, among other factors, differences in the use of countermeasures and high-resistive exercise regimes, which can influence brain fluid redistribution. Moreover, NASA astronauts who developed SANS had greater pre- and postflight WM-PVS volumes than those unaffected. These results provide evidence for a potential link between WM-PVS fluid and SANS.
Identifiants
pubmed: 35412862
doi: 10.1073/pnas.2120439119
pmc: PMC9169932
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2120439119Subventions
Organisme : NIMH NIH HHS
ID : RF1 MH123223
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Aerosp Med Hum Perform. 2018 Dec 1;89(12):1089-1091
pubmed: 30487031
J Cereb Blood Flow Metab. 2021 Jul;41(7):1563-1578
pubmed: 33183133
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4784-4791
pubmed: 28973323
AJNR Am J Neuroradiol. 2019 Nov;40(11):1878-1885
pubmed: 31624117
Sleep. 2015 Jun 01;38(6):853-8
pubmed: 26163465
Invest Ophthalmol Vis Sci. 2012 Mar 15;53(3):1422-7
pubmed: 22323469
Sci Rep. 2019 Aug 26;9(1):12351
pubmed: 31451792
Ophthalmology. 2011 Oct;118(10):2058-69
pubmed: 21849212
Neuroimage. 2020 Sep;218:116978
pubmed: 32447015
Nat Rev Neurol. 2020 Mar;16(3):137-153
pubmed: 32094487
NPJ Microgravity. 2016 Dec 19;2:2
pubmed: 28649622
N Engl J Med. 2017 Nov 2;377(18):1746-1753
pubmed: 29091569
Proc Natl Acad Sci U S A. 2019 May 21;116(21):10531-10536
pubmed: 31061119
Sci Transl Med. 2012 Aug 15;4(147):147ra111
pubmed: 22896675
JAMA Neurol. 2019 Apr 1;76(4):412-419
pubmed: 30673793
Am J Physiol Regul Integr Comp Physiol. 2018 Sep 1;315(3):R496-R499
pubmed: 29768035
J Occup Environ Med. 2014 May;56(5):477-83
pubmed: 24806559
Radiology. 2020 Jun;295(3):640-648
pubmed: 32286194
Cereb Cortex Commun. 2020;1(1):tgaa023
pubmed: 32864615
Sci Adv. 2020 Sep 4;6(36):
pubmed: 32917625
Neuropathol Appl Neurobiol. 2008 Apr;34(2):131-44
pubmed: 18208483
Lancet Neurol. 2014 Sep;13(9):904-12
pubmed: 25127232
N Engl J Med. 2018 Oct 25;379(17):1678-1680
pubmed: 30354959
Med Sci Sports Exerc. 2003 Jan;35(1):65-8
pubmed: 12544637